Cytokine and lipid metabolome effects of low-dose acetylsalicylic acid in critically ill patients with systemic inflammation: a pilot, feasibility, multicentre, randomised, placebo-controlled trial

Objective: The systemic inflammatory response syndrome (SIRS) is a dysregulated response that contributes to critical illness. Adjunctive acetylsalicylic acid (ASA) treatment may offer beneficial effects by increasing the synthesis of specialised proresolving mediators (a subset of polyunsaturated f...

Descripción completa

Detalles Bibliográficos
Autores principales: Cioccari, Luca, Luethi, Nora, Duong, Thy, Ryan, Eileen, Cutuli, Salvatore L., Lloyd-Donald, Patryck, Eastwood, Glenn M., Peck, Leah, Young, Helen, Vaara, Suvi T., French, Craig J., Orford, Neil, Dwivedi, Jyotsna, Lankadeva, Yugeesh R., Bailey, Michael, Reid, Gavin E., Bellomo, Rinaldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692583/
https://www.ncbi.nlm.nih.gov/pubmed/32900329
http://dx.doi.org/10.1016/S1441-2772(23)00390-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692583/
https://www.ncbi.nlm.nih.gov/pubmed/32900329
http://dx.doi.org/10.1016/S1441-2772(23)00390-3

Ejemplares similares